Aladdin Scientific
Ankaflavin (C007B-326167)
Ankaflavin, isolated from Monascus-Fermented red rice, is an orally active PPARγ agonist. Ankaflavin exhibits selective cytotoxic effect and induces cell death through apoptosis on cancer cells. Ankaflavin has anti-inflammatory, anti-cancer,
Ankaflavin, isolated from Monascus-Fermented red rice, is an orally active PPARγ agonist. Ankaflavin exhibits selective cytotoxic effect and induces cell death through apoptosis on cancer cells. Ankaflavin has anti-inflammatory, anti-cancer, antiatherosclerotic, and hypolipidemic effectsIn VitroAnkaflavin (0-50 µg/mL, 48 h) shows cytotoxicity against cancer cells with no significant toxicity toward normal cells. Ankaflavin (0-30 µg/mL, 0-48 h) arrests Hep G2 cell cycle at sub-G1 phase in a dose- and time-dependent manner. Ankaflavin (25 µg/mL, 48 h) induces Hep G2 cell apoptosis. MCE has not independently confirmed the accuracy of these methods. They are for reference only. Cell Cytotoxicity AssayCell Line: A549, Hep G2, MRC-5 and WI-38 Concentration: 1, 10, 25, and 50 µg/mL Incubation Time: 48 h Result: Showed cytotoxicity against A549 and Hep G2 cells in a dose-dependent manner with no significant toxicity toward normal cells (MRC-5 and WI-38). Cell Cycle AnalysisCell Line: Hep G2 cells Concentration: 15, 20, 25, and 30 µg/mL Incubation Time: 12, 24, 36, and 48 h Result: Induced a distinct sub-G1 peak in Hep G2 cells in a dose- and time-dependent manner. Apoptosis AnalysisCell Line: Hep G2 cells Concentration: 25 µg/mL Incubation Time: 48 h Result: Exhibited significant chromatin condensation (fluorescent spot) through Hoechst staining.In VivoAnkaflavin (10 mg/kg; p.o.; daily for 28 days) shows antidiabetic and anti-inflammatory activity, improves liver function and pancreatic function. MCE has not independently confirmed the accuracy of these methods. They are for reference only. Animal Model: Wistar rats (4 weeks of age), diabetes was induced by treating them with Methylglyoxal (MG) (600 mg/kg; oral) for 4 weeksDosage: 10 mg/kg Administration: Oral administration for 28 days Result: Exerted PPARγ agonist activity. Effectively reduced AGE (advanced glycation end-products) levels in serum, liver, and pancreas of MG-induced rats.Form:SolidIC50& Target:PPARγ. Specification: 0.98 Molecular Formula: C23H30O5 Molecular Weight: 386.48 PubChem CID: 15294091 Isomeric SMILES: CCCCCCCC(=O)[C@@H]1[C@H]2CC3=C(COC(=C3)/C=C/C)C(=O)[C@@]2(OC1=O)C
Specifications
- UPC:
- 51111624
- Condition:
- New
- Weight:
- 1.06 Ounces
- HazmatClass:
- No
- Quantity:
- 1
- Unit of Measurement:
- EA
- WeightUOM:
- LB
- MPN:
- A651748-10mg
- CAS:
- 50980-32-0
- Product Size:
- 10mg



